Entropy Technologies’s Day One Biopharmaceuticals DAWN Stock Holding History

Entropy Technologies’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-17,040	Closed	-$365K	–	1016
2026 Q1	$365K	Sell	17,040 -12,339	-42%	-$174K	0.02%	653
2025 Q4	$274K	Buy	+29,379	New	+$245K	0.01%	727
2025 Q3	–	Sell	-10,330	Closed	-$67.1K	–	876
2025 Q2	$67.1K	Buy	+10,330	New	+$71.1K	0.01%	749

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Entropy Technologies's DAWN Position: Q2 2026 in Review

Entropy Technologies sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 17,040 shares — an estimated $365K sold.

Entropy Technologies first reported a position in DAWN in Q2 2025 and held it in 3 quarters. The position peaked at $365K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Entropy Technologies reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Entropy Technologies sold 17,040 Day One Biopharmaceuticals shares in Q2 2026, an estimated $365K.
Entropy Technologies first reported a position in Day One Biopharmaceuticals in Q2 2025 and held it in 3 quarters.
Entropy Technologies's Day One Biopharmaceuticals position peaked at $365K in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.